Financial Data and Key Metrics Changes - In Q3 2022, the company recorded revenues of €58.3 million, representing a growth of almost 12% compared to the same period last year [7][16] - Adjusted EBITDA for the quarter amounted to €5.1 million, down from €9.7 million last year, impacted by investments and inflation-related higher expenses [8][17] - Earnings per share for the quarter were $0.02, compared to a net profit of €8.7 million in the previous year [8][22] Business Line Data and Key Metrics Changes - Materialise Manufacturing posted a 14% growth in Q3, driven by reliable rapid prototyping and growth in certified manufacturing activities [9][21] - The Medical segment grew by 13%, with software revenue increasing by 19% and medical device solutions by 10% [20] - The Software segment saw a revenue increase of 3.8%, supported by renewed licenses, but non-recurring sales decreased by 12% [18] Market Data and Key Metrics Changes - The Medical segment accounted for 37% of total revenue, while Manufacturing contributed 45% and Software 18% [16] - Cross-segment revenue from software products represented 31% of total revenue [16] Company Strategy and Development Direction - The company is focusing on sustainable growth and investing in new technologies, including the acquisition of Identify3D to enhance secure additive manufacturing operations [14] - Materialise is expanding its presence in the aerospace sector and enhancing its product offerings in medical devices and software [10][12] Management's Comments on Operating Environment and Future Outlook - Management believes that the additive manufacturing industry will continue to grow despite potential economic downturns, as companies increasingly turn to additive manufacturing for supply chain resilience [37] - The company is committed to sustainability and has shifted to renewable electricity contracts to mitigate rising energy costs [37] Other Important Information - The company’s cash position remains strong, with €150.6 million in cash and a decrease in borrowings to €83.9 million [23][24] - A credit facility agreement was entered into with KBC Bank for €50 million, which will strengthen the cash position in the future [24] Q&A Session Summary Question: Was the growth in medical software primarily from a single customer or across the industry? - Management indicated that the growth was broad across multiple medical segments, including orthopedics and cardiovascular [28] Question: Are sales cycles for software lengthening due to the current environment? - Management noted that there are no signs of lengthening sales cycles in the medical sector, but weaker investments are observed in the industrial sector [30] Question: How is the company managing inflationary costs? - Management confirmed that they are adjusting prices regularly and including indexation clauses in larger contracts to manage increased costs [31] Question: What are the risks associated with energy prices in Europe? - Management expressed confidence in the company's resilience due to the shift towards additive manufacturing and sustainability initiatives [36] Question: How is the company addressing talent acquisition and retention? - Management highlighted the establishment of talent centers globally to source and retain talent, despite challenges in the labor market [39] Question: What is the impact of inflation on costs related to Link3D and Identify3D? - Management indicated that half of the EBITDA difference from last year is due to increased investments in Link3D and Identify3D, with the other half attributed to inflation [47]

materialise innovators you can count on Q3 2022 Financial Results Conference Call October 27, 2022 www.materialise.com NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and pr ...

Financial Data and Key Metrics Changes - In Q2 2022, Materialise NV recorded revenues of €58.1 million, representing a growth of almost 15% compared to the same period last year [11][28] - Adjusted EBITDA for the quarter amounted to €4.2 million, down from €6.9 million in the previous year, impacted by investments in CO-AM solutions and inflation-related higher expenses [11][29] - Net profit for the quarter was €896,000 or €0.02 per share, compared to net profits of €3.4 million in the previous year [37] Business Line Data and Key Metrics Changes - Software segment revenue increased by 6% to €10.6 million, driven by renewed licenses and usage from deferred revenue [28][30] - Medical segment revenue grew by 19%, with software sales increasing by 52% [28][33] - Manufacturing segment revenue grew by 14.2% to €26.6 million, driven by core manufacturing business lines [28][34] Market Data and Key Metrics Changes - The manufacturing business exceeded Q2 2019 levels by more than 10%, indicating a recovery and growth beyond pre-COVID levels [14] - The industrial goods and medical device projects in contract manufacturing grew by 25%, while automotive projects remained stable at low levels [15][16] Company Strategy and Development Direction - The company is focusing on new vertical opportunities in its manufacturing business, particularly in the ACTech segment, which has shifted its focus to electric vehicle components [12][17] - Materialise plans to invest €23 million to double ACTech's capacity, supporting sustainability through additive manufacturing [25] - The company aims to maintain growth in its medical segment and expand into new business lines like eyewear and motion [63] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence that full-year 2022 revenues will be at least 10% higher than the previous year, despite challenges from inflation and talent acquisition costs [39] - The company anticipates consolidated EBITDA for the full year 2022 to be in the range of €20 million to €25 million [40] Other Important Information - Deferred revenue for maintenance and license fees increased by €3.8 million compared to the end of last year, driven by strong sales performance in the medical segments [11][28] - Operating expenses increased by 25.1% to €33.6 million, reflecting significant investments in R&D, sales, and marketing [36] Q&A Session Summary Question: Timing of the €23 million investment in ACTech - Management indicated that the first portion of the investment will be for the acquisition of the building, estimated at €6 million to €7 million, with further investments planned for 2023 and 2024 [43][45] Question: Order intake and performance in the Manufacturing segment - Management confirmed that order intake and invoicing were in equilibrium, indicating solid order intake [47] Question: Impact of inflation and talent acquisition on profitability - Management noted that increased remuneration costs due to the war for talent significantly impacted EBITDA, along with rising material and electricity costs [55][56] Question: Long-term margin potential with new business developments - Management expressed optimism about the CO-AM platform and its potential for margin generation, expecting a return to higher margins towards the end of next year [60][61]

materialise innovators you can count on Q2 2022 Financial Results Conference Call July 28, 2022 www.materialise.com NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prosp ...

[First Quarter 2022 Financial Results](index=2&type=section&id=First%20Quarter%202022%20Financial%20Results) This section provides a comprehensive overview of Materialise's financial performance for the first quarter of 2022, including key financial metrics, segment-specific results, consolidated financial statements, and non-IFRS reconciliations [Overall Financial Highlights](index=2&type=section&id=Overall%20Financial%20Highlights) Materialise reported a 16.3% increase in total revenue to **€53.0 million** for the first quarter of 2022. The company achieved a net profit of **€127k**, a significant turnaround from a net loss of **€3.6 million** in the prior-year period, primarily driven by a positive net financial result. Adjusted EBITDA saw a slight increase to **€5.4 million**, though the margin decreased to **10.3%**. The company's net cash position decreased, partly due to the acquisition of Link3D Q1 2022 Key Financial Metrics (vs. Q1 2021) | Metric | Q1 2022 (€'000) | Q1 2021 (€'000) | Change | | :--- | :--- | :--- | :--- | | **Total Revenue** | 52,961 | 45,554 | +16.3% | | **Gross Profit** | 28,884 | 24,568 | +17.6% | | **Operating Result** | 49 | 290 | -83.1% | | **Net Profit/(Loss)** | 127 | (3,642) | Turnaround to Profit | | **Adjusted EBITDA** | 5,443 | 5,341 | +1.9% | | **Adjusted EBITDA Margin** | 10.3% | 11.7% | -1.4 p.p. | - Operating expenses (R&D, S&M, G&A) increased by **17.2%** to **€29.8 million**, outpacing revenue growth and contributing to the decline in operating profit[6](index=6&type=chunk) Balance Sheet and Cash Flow Highlights (as of March 31, 2022) | Metric | March 31, 2022 (€'000) | Dec 31, 2021 (€'000) | Change | | :--- | :--- | :--- | :--- | | **Cash & Cash Equivalents** | 169,610 | 196,028 | -€26,418k | | **Gross Debt** | 93,583 | 99,107 | -€5,524k | | **Net Cash Position** | 76,027 | 96,921 | -€20,894k | | **Cash Flow from Operations (Q1)** | 11,111 | 4,231 (Q1 2021) | +162.6% | - The decrease in the net cash position was influenced by the exercise of the call option to acquire **100%** of the shares of Link3D[11](index=11&type=chunk) [Segment Performance](index=2&type=section&id=Segment%20Performance) All three business segments reported revenue growth in Q1 2022. Materialise Manufacturing led with a **26.2%** increase, followed by Medical at **13.0%** and Software at **2.6%**. The Manufacturing segment also showed a significant turnaround in profitability, with its Adjusted EBITDA margin growing to **10.8%** from **-0.8%** YoY. In contrast, both the Software and Medical segments experienced a decline in their Adjusted EBITDA margins, with Software's results impacted by investments in the newly consolidated Link3D Q1 2022 Revenue by Segment (vs. Q1 2021) | Segment | Q1 2022 Revenue (€'000) | Q1 2021 Revenue (€'000) | YoY Growth | | :--- | :--- | :--- | :--- | | **Materialise Manufacturing** | 24,131 | 19,114 | +26.2% | | **Materialise Medical** | 18,347 | 16,231 | +13.0% | | **Materialise Software** | 10,483 | 10,219 | +2.6% | Q1 2022 Adjusted EBITDA by Segment (vs. Q1 2021) | Segment | Q1 2022 Adj. EBITDA (€'000) | Q1 2021 Adj. EBITDA (€'000) | Margin (Q1 2022) | Margin (Q1 2021) | | :--- | :--- | :--- | :--- | :--- | | **Materialise Medical** | 3,227 | 4,541 | 17.6% | 28.0% | | **Materialise Manufacturing** | 2,613 | (144) | 10.8% | (0.8)% | | **Materialise Software** | 1,932 | 3,429 | 18.4% | 33.6% | - The results of Link3D have been fully consolidated within the Materialise Software segment starting from the beginning of 2022[4](index=4&type=chunk) [Consolidated Financial Statements](index=4&type=section&id=Consolidated%20Financial%20Statements) This section presents the unaudited consolidated financial statements for the three months ended March 31, 2022, including the income statement, statement of comprehensive income, statement of financial position, and statement of cash flows. The statements show a return to net profitability, stable total assets, and a significant increase in cash flow from operating activities compared to the prior-year period [Consolidated Income Statement](index=4&type=section&id=Consolidated%20Income%20Statement) This statement details the company's revenues, expenses, and net profit or loss for the first quarter of 2022, showing a return to profitability Q1 2022 Income Statement Highlights (Unaudited) | In '000 € | Q1 2022 | Q1 2021 | | :--- | :--- | :--- | | **Revenue** | 52,961 | 45,554 | | **Gross Profit** | 28,884 | 24,568 | | **Operating Profit** | 49 | 290 | | **Profit (Loss) before taxes** | 425 | (3,822) | | **Net Profit (Loss) for the period** | 127 | (3,642) | | **Basic EPS (€)** | 0.00 | (0.07) | [Consolidated Statement of Comprehensive Income](index=5&type=section&id=Consolidated%20Statement%20of%20Comprehensive%20Income) This statement presents the net profit or loss along with other comprehensive income items, reflecting the total change in equity from non-owner sources Q1 2022 Comprehensive Income (Unaudited) | In '000 € | Q1 2022 | Q1 2021 | | :--- | :--- | :--- | | **Net profit (loss) for the period** | 127 | (3,642) | | **Other comprehensive income, net of taxes** | 1,416 | 492 | | **Total comprehensive income (loss)** | 1,543 | (3,150) | [Consolidated Statement of Financial Position](index=6&type=section&id=Consolidated%20Statement%20of%20Financial%20Position) This statement provides a snapshot of the company's assets, liabilities, and equity as of March 31, 2022, indicating a stable financial structure Financial Position Highlights (Unaudited) | In '000 € | March 31, 2022 | Dec 31, 2021 | | :--- | :--- | :--- | | **Total Non-current assets** | 185,040 | 155,605 | | **Total Current assets** | 229,074 | 257,803 | | **Total Assets** | 414,115 | 413,408 | | **Total Equity** | 234,115 | 232,578 | | **Total Liabilities** | 179,994 | 180,830 | [Consolidated Statement of Cash Flows](index=8&type=section&id=Consolidated%20Statement%20of%20Cash%20Flows) This statement summarizes the cash inflows and outflows from operating, investing, and financing activities for the first quarter of 2022 Q1 2022 Cash Flow Summary (Unaudited) | In '000 € | Q1 2022 | Q1 2021 | | :--- | :--- | :--- | | **Net cash flow from operating activities** | 11,111 | 4,231 | | **Net cash flow used in investing activities** | (30,820) | (2,949) | | **Net cash flow from (used in) financing activities** | (7,452) | (5,384) | | **Net decrease of cash & cash equivalents** | (27,161) | (4,102) | - Investing activities included a significant cash outflow of **€27.4 million** for the acquisition of a subsidiary (Link3D), which was the primary driver of the net decrease in cash[27](index=27&type=chunk) [Non-IFRS Measures and Reconciliations](index=3&type=section&id=Non-IFRS%20Measures%20and%20Reconciliations) This section details the company's use of non-IFRS measures, specifically EBITDA and Adjusted EBITDA, which management believes are important for evaluating operational performance by excluding long-term investment and financing decisions. It provides reconciliations from IFRS net profit to both consolidated Adjusted EBITDA and segment-level Adjusted EBITDA - Management uses EBITDA and Adjusted EBITDA as supplemental measures to assess the performance of day-to-day operations and the company's ability to grow[16](index=16&type=chunk) - Adjusted EBITDA is calculated by adding back share-based compensation, acquisition-related expenses, impairments, and revaluations to EBITDA[16](index=16&type=chunk) [Reconciliation to EBITDA and Adjusted EBITDA](index=10&type=section&id=Reconciliation%20to%20EBITDA%20and%20Adjusted%20EBITDA) This reconciliation details the adjustments made from net profit to derive EBITDA and Adjusted EBITDA, providing a clearer view of core operational profitability Q1 2022 Reconciliation to Adjusted EBITDA (Unaudited) | In '000 € | Q1 2022 | Q1 2021 | | :--- | :--- | :--- | | **Net profit (loss) for the period** | 127 | (3,642) | | Income taxes | 298 | (181) | | Financial expenses | 1,289 | 4,701 | | Financial income | (1,665) | (589) | | Depreciation and amortization | 5,442 | 5,081 | | **EBITDA** | **5,491** | **5,371** | | Share-based compensation expense | (48) | (415) | | Acquisition-related expenses | — | 385 | | **Adjusted EBITDA** | **5,443** | **5,341** | [Segment P&L and Reconciliation](index=11&type=section&id=Segment%20P%26L%20and%20Reconciliation) This section provides a breakdown of segment-level revenues and Adjusted EBITDA, along with a reconciliation from operating profit to total segment Adjusted EBITDA Q1 2022 Segment Adjusted EBITDA (Unaudited) | In '000 € | Software | Medical | Manufacturing | Total Segments | Unallocated | Consolidated | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | **Revenues** | 10,483 | 18,347 | 24,131 | 52,961 | 0 | 52,961 | | **Segment (adj) EBITDA** | 1,932 | 3,227 | 2,613 | 7,772 | (2,329) | 5,443 | | **Segment (adj) EBITDA %** | 18.4% | 17.6% | 10.8% | 14.7% | N/A | 10.3% | Reconciliation from Operating Profit to Segment Adjusted EBITDA | In '000 € | Q1 2022 | Q1 2021 | | :--- | :--- | :--- | | **Operating profit** | 49 | 289 | | Depreciation and amortization | 5,442 | 5,081 | | Corporate R&D | 816 | 692 | | Corporate headquarter costs | 2,106 | 2,648 | | Other operating income (expense) | (640) | (855) | | **Segment adjusted EBITDA** | **7,772** | **7,855** |

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC ...

Materialise NV (NASDAQ:MTLS) Q1 2022 Earnings Conference Call April 28, 2022 8:30 AM ET Company Participants Harriet Fried - IR Peter Leys - Executive Chairman Johan Albrecht - EVP & CFO Wilfried Vancraen - Founder, CEO & Director Conference Call Participants Jacob Stephan - Lake Street Capital Noelle Dilts - Stifel, Nicolaus & Company Gregory Ramirez - Bryan Garnier & Co Ltd Jason Celino - KeyBanc Capital Markets Operator Good day, and thank you for standing by. Welcome to the Q1 2022 Materialise Financial ...

materialise innovators you can count on Q1 2022 Financial Results Conference Call April 28, 2022 www.materialise.com NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and pros ...

Materialise NV (NASDAQ:MTLS) Q4 2021 Earnings Conference Call March 3, 2022 8:30 AM ET Company Participants Fried Vancraen ??? Founder and Chief Executive Officer Johan Albrecht ??? Chief Financial Officer Peter Leys ??? Executive Chairman Harriet Fried ??? Investor Relations Conference Call Participants Troy Jensen ??? Lake Street Capital Devin Au ??? KeyBanc Capital Markets Noelle Dilts ??? Stifel Gregory Ramirez ??? Bryan Garnier Bhavna Advani ??? JPMorgan Operator Good day. Thank you for standing ...

materialise innovators you can count on Q4 2021 Financial Results Conference Call March 3, 2022 www.materialise.com NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prosp ...